A new 3D bio-printer that produces human-like tissue holds the potential to revolutionize the discovery of new drugs for cancer, heart disease and arthritis.

Emergen Research Logo The global Herbal Medicine Market size was USD 201.80 billion in 2022 and is expected to register a revenue CAGR of 7 ...

Celebrity gangster Dave Courtney said he enjoyed a ‘wicked and superb’ before shooting himself in the head at his southeast ...

BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or "Company") announces that, further to its news release dated February 13, 2025, its principal regulator, the British Columbia Securities Commission ...

Research led by York University's Faculty of Health reveals how a specific mutation in a protein called TRAF1 can shut down an overactive immune response, dramatically reducing inflammation in mice.

A single mutation at position valine 196 (V196), the researchers found, selectively blocks TRAF1’s interaction with another protein, which dampens a major inflammatory pathway triggered by receptors ...

Initiated the Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS) and the Phase 3 ...

Orbital mobility took center-stage in the space industry last year, with venture capitalists funneling massive sums into startups developing tech for ... an MA in art history from the Courtauld ...

HCL Tech's six-month beta stands at 0.5068, suggesting it is less volatile than the broader market.

Mar. 6, 2025 — The enormous computing resources needed to train neural networks for artificial intelligence (AI) result in massive power consumption. Researchers have developed a method that is ...

Every Cure was co-founded by a Penn immunologist after discovering an off-label treatment for his own rare disease.